Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.060
-0.160 (-7.21%)
At close: Jan 9, 2026, 4:00 PM EST
2.100
+0.040 (1.94%)
After-hours: Jan 9, 2026, 6:24 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $260.19 million as of January 9, 2026. Its market cap has increased by 17.74% in one year.
Market Cap
260.19M
Enterprise Value
155.76M
1-Year Change
17.74%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $260.19M, an increase of 122.32%. That is a compound annual growth rate of 18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 280.40M | 13.85% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |